Norvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Ritonavir.
Product ID | 0074-2340_ff281f75-bfea-433a-8d28-d33cdb898f00 |
NDC | 0074-2340 |
Product Type | Human Prescription Drug |
Proprietary Name | Norvir |
Generic Name | Ritonavir |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-08-16 |
Marketing Category | NDA / |
Application Number | NDA022417 |
Labeler Name | AbbVie Inc. |
Substance Name | RITONAVIR |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2022-08-16 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0074-1940 | Norvir | Ritonavir |
0074-2340 | Norvir | Ritonavir |
0074-3333 | Norvir | Ritonavir |
0074-3399 | Norvir | Ritonavir |
50090-1162 | Norvir | Ritonavir |
53808-1119 | Norvir | Ritonavir |
67296-1234 | Norvir | Norvir |
0054-0407 | Ritonavir | Ritonavir |
31722-597 | Ritonavir | Ritonavir |
60687-364 | Ritonavir | Ritonavir |
60687-420 | Ritonavir | Ritonavir |
65162-061 | Ritonavir | Ritonavir |
65862-687 | Ritonavir | Ritonavir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NORVIR 74655713 2001944 Live/Registered |
ABBVIE INC. 1995-04-04 |